3rd Mastering HR Summit 2012

North West Business Group22 - 23 February 2012, Istanbul, Turkey.
The role of Human Resources is changing as fast as technology and the global marketplace. Historically, the HR department was viewed as administrative overhead.

HR processed payroll, handled benefits administration, kept personnel files and other records, managed the hiring process, and provided other administrative support to the business. Those times have changed. The positive result of these changes is that HR professionals have the opportunity to play a more strategic role in the business. The challenge for HR managers is to keep up to date with the latest HR innovations - technological, legal, and otherwise.

The 3rd Mastering HR Summit 2012 will discuss the best practices in HR management, in other words how HR managers can anticipate and address some of the most challenging HR issues this year.

The event will give you the information you need to know about these current HR challenges and how to most effectively manage them in your workplace. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • Inclusive Talent Management as an enabler of business turnaround
  • How Connecting Performance Management & Talent is going to help you?
  • New perspectives for very experienced persons (VEPs)
  • Working with an HR Strategy to ensure employee retention & effective performance
  • Managing Talent from different cultures with a global model
  • How to connect HR investments to the firm's bottom line
  • HR Transformation and engagement - Business case
  • TQM Tools for employee empowerment
  • Motivation and benefit systems and their impact on performance - a critical view
  • How to set the strategic agenda for Human Resources

Joins some of the experts like:

  • President EAPM, Secretary General WFPMA
  • The Hertz Corporation, Vice President - Global Talent Management
  • Tetra Pak, VP Human Resources, Packaging Solutions & Cluster Coordination
  • Medtronic, Vice President Human Resources Europe & Central Asia
  • Ericsson, Vice President Human Resources & Organization
  • Beiersdorf AG, Regional HR Vice President, Asia and Australia
  • Schneider Electric France, HR Vice President Country Partner
  • Papyrus Group, Senior Vice President Human Resources
  • Citi, Senior Vice President Human Resources EMEA Consumer
  • Mercedes-Benz, General Manager – Business Support
  • Swisscom, Head Group Talent Management
  • Vodafone, Human Resources Director
  • BNP Paribas, Head of UK Recruitment & European Campus Recruitment
  • Eczacıbaşı Holding, HR Director, Corporate Human Resources
  • Gulf Bridge International, Director of HR & Corporate Planning
  • Abdiibrahim, HR Manager
  • TÜV SÜD, Former Head of Division Academy
  • And many more...

Hear from experts actively working in the industry for corporates;

  • Employing close to 1 million people.
  • Operating in more than 250 countries.
  • Presented in 6 continents.
  • With 191€ billion in revenue (2010).

This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

After this two day conference, you will be empowered to lead your HR team as a true strategic partner that will improve your organization's competitive advantages and sustainability.

For further information and registration, please visit:
http://nwbg.eu/all-events/3rd-master-hr-sumit-2011/

Most Popular Now

Cannabis extract helps reset brain function in psy…

Research from King's College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psyc...

For first time in 40 years, cure for acute leukemi…

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefitted from new treatments, there has been no encouraging news for most leukemi...

New cancer treatment uses enzymes to boost immune …

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy. The enzyme, PEG-KYNase, does not directly kill can...

Bayer accelerates six new startups

Changing the experience of health: that's the focus of the six startups which the Bayer G4A team has included in the Accelerator program this year. The young companies fr...

Novartis receives European Commission approval of …

Novartis today announced that the European Commission (EC) has approved Kymriah® (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pe...

Shire completes sale of oncology franchise

Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion. The franchise includes the...

Antioxidant reduces risk for second heart attack, …

Doctors have long known that in the months after a heart attack or stroke, patients are more likely to have another attack or stroke. Now, a paper in the Journal of the A...

Novartis to divest the Sandoz US dermatology busin…

Novartis today announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids po...

SOLAR-1 trial of Novartis investigational alpha-sp…

Novartis today announced the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) has met the primary endpoint s...

New tablet production facility in Ingelheim: Cente…

Boehringer Ingelheim held a groundbreaking ceremony for the construction of a new production facility for innovative drugs. This new Solids Launch facility will focus on ...

Tezepelumab granted Breakthrough Therapy Designati…

AstraZeneca and its partner Amgen Inc. (Amgen) today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab...

Pfizer terminates domagrozumab (PF-06252616) clini…

Pfizer Inc. (NYSE: PFE) announced that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrop...